LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | R406 | 3.33 | uM | LJP6 | 1 | C14 | 72 | hr | 1235 | 3220 | 4156 | 0.7748 | 0.6795 |
| MCF7 | R406 | 3.33 | uM | LJP6 | 2 | C14 | 72 | hr | 1235 | 3087 | 4156 | 0.7428 | 0.6339 |
| MCF7 | R406 | 3.33 | uM | LJP6 | 3 | C14 | 72 | hr | 1235 | 2855 | 4156 | 0.6869 | 0.5545 |
| MCF7 | Pictilisib | 3.33 | uM | LJP6 | 1 | D20 | 72 | hr | 1235 | 1213 | 4156 | 0.2919 | -0.0077 |
| MCF7 | Pictilisib | 3.33 | uM | LJP6 | 2 | D20 | 72 | hr | 1235 | 1111 | 4156 | 0.2673 | -0.0426 |
| MCF7 | Pictilisib | 3.33 | uM | LJP6 | 3 | D20 | 72 | hr | 1235 | 1250 | 4156 | 0.3008 | 0.0050 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 1235 | 4682 | 4156 | 1.1265 | 1.1800 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 1235 | 4237 | 4156 | 1.0194 | 1.0277 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 1235 | 4350 | 4156 | 1.0466 | 1.0664 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 1 | O02 | 72 | hr | 1235 | 1324 | 4156 | 0.3186 | 0.0303 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 1235 | 1248 | 4156 | 0.3003 | 0.0043 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 1235 | 1321 | 4156 | 0.3178 | 0.0293 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 1235 | 1129 | 4156 | 0.2716 | -0.0364 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 1235 | 1309 | 4156 | 0.3150 | 0.0252 |
| MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 1235 | 1288 | 4156 | 0.3099 | 0.0180 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1235 | 1084 | 4156 | 0.2608 | -0.0518 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1235 | 1009 | 4156 | 0.2428 | -0.0775 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1235 | 1098 | 4156 | 0.2642 | -0.0470 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1235 | 1131 | 4156 | 0.2721 | -0.0357 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1235 | 1251 | 4156 | 0.3010 | 0.0053 |
| MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1235 | 1088 | 4156 | 0.2618 | -0.0505 |
| MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1235 | 1859 | 4156 | 0.4473 | 0.2135 |
| MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1235 | 1866 | 4156 | 0.4490 | 0.2159 |
| MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1235 | 2111 | 4156 | 0.5079 | 0.2998 |
| MCF7 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1235 | 1123 | 4156 | 0.2702 | -0.0385 |